More articles from Original Article

Open Access
Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends
Mengdi Cao, Changfa Xia, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Shaoli Zhang, Yi Teng, Qianru Li, Nuopei Tan, Jiachen Wang and Wanqing Chen

Cancer Biology & Medicine August 2024, 21 (8) 679-691; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0149
Open Access
Global, regional, and national burden of early-onset gastric cancer
Nuopei Tan, Hongliang Wu, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Yi Teng, Qianru Li, Jiachen Wang, Changfa Xia and Wanqing Chen

Cancer Biology & Medicine August 2024, 21 (8) 667-678; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0159
Open Access
Effectiveness of colorectal cancer screening integrating non-genetic and genetic risk: a prospective study based on UK Biobank data
Yu Zhang, Chao Sheng, Zhangyan Lyu, Hongji Dai, Fangfang Song, Fengju Song, Yubei Huang and Kexin Chen

Cancer Biology & Medicine August 2024, 21 (8) 712-723; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0096
Open Access
Impact of cancer diagnosis on life expectancy by area-level socioeconomic groups in New South Wales, Australia: a population-based study
Md Mijanur Rahman, Michael David, David Goldsbury, Karen Canfell, Kou Kou, Paramita Dasgupta, Peter Baade and Xue Qin Yu

Cancer Biology & Medicine August 2024, 21 (8) 692-702; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0166
Open Access
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis
Shirong Tan, Xiangyu Sun, Haoran Dong, Mozhi Wang, Litong Yao, Mengshen Wang, Ling Xu and Yingying Xu

Cancer Biology & Medicine July 2024, 21 (7) 606-635; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0309
Open Access
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba

Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301
Open Access
Decreased LDHB expression in breast tumor cells causes NK cell activation and promotes tumor progression
Zhihong Luo, Xiaohua Huang, Xinyi Xu, Kefeng Wei, Yi Zheng, Ke Gong and Wenhua Li

Cancer Biology & Medicine June 2024, 21 (6) 513-540; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0382
Open Access
Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma
Yuexiang Liang, Guannan Sheng, Yu Guo, Yiping Zou, Hanhan Guo, Zhifei Li, Shaofei Chang, Quan Man, Song Gao and Jihui Hao

Cancer Biology & Medicine May 2024, 21 (5) 416-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0363
Open Access
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuanyuan Chen and Ming Chen

Cancer Biology & Medicine May 2024, 21 (5) 433-444; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0373
Open Access
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
Yuwei Li, Yuzheng Xu, Caijin Lin, Xi Jin, Ding Ma and Zhiming Shao

Cancer Biology & Medicine May 2024, 21 (5) 400-415; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0492

Main menu

User menu

Search

More articles from Original Article

Pages

Navigate

More Information

For Authors

Journal Services